Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
MEDIGENE - BUY | EUR16.7 (+94%) Q1 results and update – a strong period for bus dev Financials – full year revenue guidance upgraded Three recent deals: new opportunities, clear focus Step-by-step – the pipeline making progress Positive outlook
MEDIGENE - | EUR16.7 vs EUR16.2 (+59%) Multi-program license to Cytovant Sciences in Asia Medigene out-licenses multiple programs to Cytovant Attractive out-licensing terms for Medigene Collaborations de-risking development and providing upside Positive outlook continues to build momentum
MEDIGENE - BUY | EUR16.2 vs. 16.1(+83%) Medigene 2018 results – progress and potential Solid 2018 Financial results – restatements but no surprises Pipeline filling and progressing Collaborations expanding Positive profile for 2019
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.